Anti-human embryonic stem cell monoclonal antibody hesca-2 binds to a glycan epitope commonly found on carcinomas

Stem Cells and Development

Volumn 20, Issue 3, 2011, Pages 515-525

  Shoreibah, Mohamed G ^a   Jackson, Crystal L ^a   Price, Paul W ^a   Meagher, Richard ^b   Godwin, Andrew K ^c   Cai, Qi ^c   Gildersleeve, Jeffrey C ^d  

^a Abeome Corporation   (United States)

^b University of Georgia   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; EPITOPE; GLYCAN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HESCA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CANCER CELL CULTURE; COLON CARCINOMA; CROSS REACTION; CYTOTOXICITY; DRUG BINDING; EMBRYONIC STEM CELL; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY AFFINITY; ANTIGENS, SURFACE; CELL LINE; CROSS REACTIONS; DISACCHARIDES; EMBRYONIC STEM CELLS; EPITOPES; HUMANS; L-LACTATE DEHYDROGENASE; MICE; MICROARRAY ANALYSIS; MICROSCOPY, FLUORESCENCE; NEOPLASMS; NEOPLASTIC STEM CELLS; POLYSACCHARIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952146856     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0172     Document Type: Article

References (59)

1. Henderson JK, JS Draper, HS Baillie, S Fishel, JA Thomson, H Moore and PW Andrews. (2002). Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20:329-337. (Pubitemid 34765092)
2. Carpenter MK, E Rosler and MS Rao. (2003). Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5:79-88. (Pubitemid 36418429)
3. Zeng X, T Miura, Y Luo, B Bhattacharya, B Condie, J Chen, I Ginis, I Lyons, J Mejido, RK Puri, MS Rao and WJ Freed. (2004). Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22:292-312. (Pubitemid 38736614)
4. Badcock G, C Pigott, J Goepel and PW Andrews. (1999). The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res 59: 4715-4719. (Pubitemid 29428981)
5. Brimble SN, ES Sherrer, EW Uhl, E Wang, S Kelly, AH Merrill Jr., AJ Robins and TC Schulz. (2007). The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 25:54-62. (Pubitemid 46052974)
6. Przyborski SA. (2001). Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting. Stem Cells 19:500-504. (Pubitemid 33095845)
7. Sidhu KS and BE Tuch. (2006). Derivation of three clones from human embryonic stem cell lines by FACS sorting and their characterization. Stem Cells Dev 15:61-69.
8. Ferrandina G, G Bonanno, L Pierelli, A Perillo, A Procoli, A Mariotti, M Corallo, E Martinelli, S Rutella, A Paglia, G Zannoni, S Mancuso and G Scambia. (2007). Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 18:506-514.
9. Ferrandina G, E Martinelli, M Petrillo, MG Prisco, G Zannoni, S Sioletic and G Scambia. (2009). CD133 antigen expresio n in ovarian cancer. BMC Cancer 9:221-229.
10. Kusumbe AP, AM Mali and SA Bapat. (2009). CD133- expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 27:498-508.
11. Bonfanti L. (2006). PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol 80:129-164. (Pubitemid 44739166)
12. Gascon E, L Vutskits and JZ Kiss. (2007). Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 56:101-118. (Pubitemid 350100865)
13. Plaia TW, R Josephson, Y Liu, X Zeng, C Ording, A Toumadje, SN Brimble, ES Sherrer, EW Uhl, WJ Freed, TC Schulz, A Maitra, MS Rao and JM Auerbach. (2006). Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells 24:531-546. (Pubitemid 44464757)
14. Wang L, TC Schulz, ES Sherrer, DS Dauphin, S Shin, AM Nelson, CB Ware, M Zhan, CZ Song, X Chen, SN Brimble, A McLean, MJ Galeano,EWUhl, KADAmour, JD Chesnut, MS Rao, CA Blau and AJ Robins. (2007). Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110:4111-4119. (Pubitemid 350248470)
15. Harlow E and D Lane. (1998). Using Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p 495.
16. Price PW, EC McKinney, Y Wang, LE Sasser, MK Kandasamy, L Matsuuchi, C Milcarek, RB Deal, DG Culver and RB Meagher. (2009). Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas. J Immunol Methods 343:28-41.
17. Gildersleeve JC, O Oyelaran, JT Simpson and B Allred. (2008). Improved procedure for direct coupling of carbohydrates to proteins via reductive amination. Bioconjugate Chem 19:1485-1490. (Pubitemid 352032350)
18. Oyelaran OO, Q Li, DF Farnsworth and JC Gildersleeve. (2009). Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res 8:3529-3538.
19. Oyelaran O, LM McShane, L Dodd and JC Gildersleeve. (2009). Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res 8:4301-4310.
20. Song EH and NLB Pohl. (2009). Carbohydrate arrays: recent developments in fabrication and detection methods with applications. Curr Opin Chem Biol 13:626-632.
21. Oyelaran O and JC Gildersleeve. (2009). Glycan arrays: recent advances and future challenges. Curr Opin Chem Biol 13:406-413.
22. Liu Y, AS Palma and T Feizi. (2009). Carbohydrate microarrays: key developments in glycobiology. Biol Chem 390:647-656.
23. Jones RB, A Gordus, JA Krall and G MacBeath. (2006). A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439:168-174. (Pubitemid 43083134)
24. Kobata A and V Ginsburg. (1972). Oligosaccharides of human milk. 3. Isolation and characterization of a new hexasaccharide, lacto-N-hexaose. J Biol Chem 247:1525-1529.
25. Yamashita K, Y Tachibana and A Kobata. (1977). Oligosaccharides of human milk:structures of three lacto-Nhexaose derivatives with H-haptenic structure. Arch Biochem Biophys 182:546-555. (Pubitemid 8161064)
26. Dua VK, K Goso, VE Dube and CA Bush. (1985). Characterization of lacto-N-hexaose and two fucosylated derivatives from human milk by high-performance liquid chromatography and proton NMR spectroscopy. J Chromatogr 328:259-269. (Pubitemid 15068246)
27. Loo D, N Pryer, P Young, T Liang, S Coberly, KL King, K Kang, P Roberts, M Tsao, X Xu, B Potts and JP Mather. (2007). The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo. Mol Cancer Ther 6:856-865. (Pubitemid 46554555)
28. Coberly SK, FZ Chen, MP Armanini, Y Chen, PF Young, JP Mather and DT Loo. (2009). The RAV12 monoclonal antibody recognizes the N-linked glycotope RAAG12: expression in human normal and tumor tissues. Arch Pathol Lab Med 133:1403-1412.
29. Rettig WJ, C Cordon-Cardo, JS Ng, HF Oettgen, LJ Old and KO Lloyd. (1985). High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res 45: 815-821. (Pubitemid 15161085)
30. Gooi HC, LK Williams, K Uemura, EF Hounsell, RA McIlhinney and Feizi T. (1983). A marker of human foetal endoderm defined by a monoclonal antibody involves type 1 blood group chains. Mol Immunol 20:607-613. (Pubitemid 13068158)
31. Williams LK, A Sullivan, RA McIlhinney and AM Neville. (1982). A monoclonal antibody marker of human primitive endoderm. Int J Cancer 30:731-738. (Pubitemid 13223565)
32. Ohbayashi H, T Endo, K Yamashita, M Kuroki, Y Matsuoka and A Kobata. (1989). Novel methods to determine the epitopes on the asparagine-linked oligosaccharides of glycoproteins. Anal Biochem 182:200-206. (Pubitemid 19277091)
33. Kabat EA, J Liao, J Shyong and EF Osserman. (1982). A monoclonal IgM lambda macroglobulin with specificity for lacto-N-tetraose in a patient with bronchogenic carcinoma. J Immunol 128:540-544. (Pubitemid 12168397)
34. Nozawa S, S Narisawa, K Kojima, M Sakayori, R Iizuka, H Mochizuki, T Yamauchi, M Iwamori and Nagai Y. (1989). Human monoclonal antibody (HMST-1) against lacto-series type 1 chain and expression of the chain in uterine endometrial cancers. Cancer Res 49:6401-6406. (Pubitemid 20000944)
35. Lanctot PA, FH Gage and AP Varki. (2007). The glycans of stem cells. Curr Opin Chem Biol 11:373-380. (Pubitemid 47302845)
36. Heiskanen A, T Hirvonen, H Salo, U Impola, A Olonen, A Laitinen, S Tiitinen, S Natunen, O Aitio, H Miller-Podraza, M Wuhrer, AM Deelder, J Natunen, J Laine, P Lehenkari, J Saarinen, T Satomaa and L Valmu. (2009). Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 26:367-384.
37. Satomaa T, A Heiskanen, M Mikkola, C Olsson, M Blomqvist, M Tiittanen, T Jaatinen, O Aitio, A Olonen, J Helin, J Hiltunen, J Natunen, T Tuuri, T Otonkoski, J Saarinen and J Laine. (2009). The N-glycome of human embryonic stem cells. BMC Cell Biol 2:10:42.
38. Sell S. (2004). Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51:1-28. (Pubitemid 38781748)
39. Soltysova A, V Altanarova and C Altaner. (2005). Cancer stem cells. Neoplasma 52:435-440. (Pubitemid 41809399)
40. Martinez-Clement JA, EJ Andreu and F Prosper. (2006). Somatic stem cells and the origin of cancer. Clin Transl Oncol 8:647-663.
41. Bertolini G, L Roz, P Perego, M Tortoreto, E Fontanella, L Gatti, G Pratesi, A Fabbri, F Andriani, S Tinelli, E Roz, R Caserini, Lo S Vullo, T Camerini, L Mariani, D Delia, E Calabro' , U Pastorino and G Sozzi. (2009). Highly tumorigenic lung cancer CD133 cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106:16281-16286.
42. Buess M, M Rajski, BML Vogel-Durrer, R Herrmann and C Rochlitz. (2009). Tumor-endothelial interaction links the CD44=CD24- phenotype with poor prognosis in earlystage breast cancer. Neoplasia 11:987-1002.
43. Singh S, ID Clarke, T Hide and PB Dirks. (2004). Cancer stem cells in nervous system tumors. Oncogene 23:7267-7273. (Pubitemid 39382160)
44. Bidlingmaier S, X Zhu and B Liu. (2008). The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86:1025-1032.
45. Wright MH, AM Calcagno, CD Salcido, MD Carlson, SV Ambudkar and L Varticovski. (2008). Brca1 breast tumors contain distinct CD44=CD24 and CD133 cells with cancer stem cell characteristics. Breast Cancer Res 10:R10.
46. Yang RY, GA Rabinovich and FT Liu. (2008). Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17.
47. Rabinovich GA and MA Toscano. (2009). Turning sweet on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338-352.
48. Consortium for Functional Glycomics (CFG). Available at: www.functionalglycomics.org=glycomics=publicdata= primaryscreen.jsp
49. Saussez S, C Decaestecker, S Cludts, P Ernoux, D Chevalier, Smetana K Jr., S Andre, X Leroy and HJ Gabius. (2009). Adhesion=growth-regulatory tissue lectin galectin-1 in relation to angiogenesis=lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer Res 29:59-65.
50. Chan J, K ODonoghue, M Gavina, Y Torrente, N Kennea, H Mehmet, H Stewart, DJ Watt, JE Morgan and NM Fisk. (2006). Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24:1879-1891. (Pubitemid 44474164)
51. Sakaguchi M, T Shingo, T Shimazaki, HJ Okano, M Shiwa, S Ishibashi, H Oguro, M Ninomiya, T Kadoya, H Horie, A Shibuya, H Mizusawa, F Poirier, H Nakauchi, K Sawamoto and H Okano. (2006). A carbohydrate-binding protein, galectin- 1, promotes proliferation of adult neural stem cells. Proc Natl Acad Sci U S A 103:7112-7117.
52. Lee MY, SH Lee, JH Park and HJ Han. (2009). Interaction of galectin-1 with caveolae induces mouse embryonic stem cell proliferation through the Src, ERas, Akt and mTOR signaling pathways. Cell Mol Life Sci 66:1467-1478.
53. Vas V, R Fajka-Boja, G Ion, V Dudics, E Monostori and F Uher. (2005). Biphasic effect of recombinant galectin-1 on the growth and death of early hematopoietic cells. Stem Cells 23:279-287. (Pubitemid 40239522)
54. Garner OB and LG Baum. (2008). Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem Soc Trans 36(Pt 6):1472-1477.
55. Friedrichs J, A Manninen, DJ Muller and J Helenius. (2008). Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV. J Biol Chem 283:32264-32272.
56. Saravanan C, FT Liu, IK Gipson and N Panjwani. (2009). Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci 15:122(Pt20):3684-3693.
57. Nakahara S and A Raz. (2008). Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem 8:22-36. (Pubitemid 351445058)
58. Saussez S and R Kiss. (2006). Galectin-7. Cell Mol Life Sci 63:686-697.
59. Lajoie P, JG Goetz, JW Dennis and IR Nabi. (2009). Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol 185:381-385.